Über uns

Biotype GmbH, a German biotechnology company with over 20 years of history, has successfully positioned itself as trusted provider of state-of-the-art solutions for molecular diagnostics in Europe. Biotype develops, manufactures, and distributes molecular in-vitro diagnostic kits for the detection and quantification of DNA and RNA based biomarkers. The assays support diagnosis and therapy in various molecular applications, such as oncology, infectious diseases, forensics, dermatology and veterinary.

Biotype initially started as a biotechnology company developing molecular diagnostic tests and has grown into a full-service provider offering the complete value chain in molecular in-vitro diagnostics. All our in-house developed tests are multiplex PCR-based and run either on established laboratory platforms or on our proprietary Modaplex device.

The Modaplex system provides a novel real-time quantification procedure through the unique combination of PCR and simultaneous capillary electrophoresis. This technology enables the examination of up to 50 RNA and DNA markers in a single sample. With little hands-on time and a simple workflow, it allows to detect all types of genetic aberrations.

Biotype’s contract development & manufacturing services cover all challenges from the idea up to the realization of a marketable product. One of our assets is platform and biomarker flexibility, meaning we design and develop molecular diagnostic assays optimized to customer needs, ranging from a prototype via RUO to CE-IVD.

The company's goal is to provide customers, such as laboratories, pharmaceutical, and diagnostic companies, with quality and robust molecular diagnostic tools and services.

Impressum